Challenges and Opportunities in Achieving Asthma Remission

Area of Science:

• Pulmonology
• Immunology
• Pharmacology

Background:

• Asthma is a global chronic inflammatory respiratory disease with significant morbidity and healthcare costs.
• Achieving long-term asthma remission remains a significant clinical challenge despite treatment advancements.

Purpose of the Study:

• To review the potential for asthma remission, focusing on biologic agents in severe asthma management.
• To evaluate if long-term disease control and remission are achievable goals with current therapies.

Main Methods:

• Systematic literature review (1971-2025) of clinical trials, meta-analyses, and real-world evidence.
• Analysis of biologic therapies targeting IL-5, IL-4/IL-13, IgE, and TSLP.
• Outcomes assessed included symptom control, exacerbations, lung function, and oral corticosteroid use.

Main Results:

• Biologics significantly improve asthma control and reduce exacerbation frequency.
• Complete long-term remission (symptoms, inflammation, drug independence) is not yet consistently achievable.
• Biologics reduce oral corticosteroid dependency, but remission sustainability requires further investigation.

Conclusions:

• Biologic therapies represent a major advancement in severe asthma treatment, enhancing symptom control and reducing exacerbations.
• Complete asthma remission remains an elusive goal, necessitating further research.
• Standardized remission criteria, improved patient stratification, and long-term studies are crucial for achieving sustained asthma control and remission.